| | SYNTHESIS AND TESTING LABORATORY SERVICES FOR RESEARCH | CRESTONE, INC. | $98,948 | VETERANS AFFAIRS, DEPARTMENT OF | VETERANS AFFAIRS, DEPARTMENT OF | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN23HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; EXPERIMENTAL DEVELOPMENT | Aug 7, 2024 | Sep 1, 2024 | Aug 31, 2025 |
| | SYNTHESIS AND TESTING OF NOVEL ANTIBIOTIC CHEMICAL COMPOUNDS FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER RESEARCH DEPARTMENT | CRESTONE, INC. | $102,140 | VETERANS AFFAIRS, DEPARTMENT OF | VETERANS AFFAIRS, DEPARTMENT OF | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN23HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; EXPERIMENTAL DEVELOPMENT | Aug 17, 2023 | Sep 1, 2023 | Aug 31, 2024 |
| | TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES. | CRESTONE, INC. | $27,049,982 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jun 29, 2020 | Jul 1, 2020 | Aug 19, 2026 |
| | TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 | CRESTONE, INC. | $31,943,633 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 5, 2019 | Sep 9, 2019 | Jan 31, 2027 |
| | IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS. | CRESTONE, INC. | $5,944,542 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541711 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jun 27, 2015 | Jun 27, 2015 | Jun 30, 2019 |